Besides serum EPO deficiency, a serum EPO-resistant state may also be involved in the pathophysiology of posttransplant anemia, possibly related to risk factors persisting (iron deficiency, inflammation, or hyperparathyroidism) or acquired in the posttransplant milieu (infections or myelotoxic drugs).15 This evidence concerns the gene EPO and Iron deficiency anemia.